Share Price:

APNASPENAspen Pharmacare Hldgs16717341 (2.08%)
Our Response to Covid
Country Sites

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Our 2026 Integrated Report is here!

Last week, the Group published Aspen’s 2026 Integrated Report. For the first time, the suite brings together three complementary publications: the Integrated Report, the Governance and Remuneration Report and the Sustainability Report. Read together, they offer a clear and connected view of how Aspen creates and protects value, while demonstrating our commitment to transparent reporting and leading global practices.
ir-2026-feature

Today, we hear from Sne Ndlela, Group Head: Sustainability and Transformation, as she unpacks Aspen’s 2026 Integrated Reporting Suite, reflecting on the progress we have made together, the priorities shaping our future and how we are strengthening our position as a responsible global pharmaceutical organisation, uniquely placed to help enhance access to medicines in Africa and around the world.

 

Click here to watch: Aspen News: Executive Corner – Integrated Report 2026 | Videos & Movies on Vimeo

Facebook
Twitter
LinkedIn

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below:

Human Capital
Legal

Supply Chain

Treasury
Ethics & Compliance
Risk & Sustainability
Digital Technology

Tax